These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4566488)

  • 21. [Correlation of the toxic effects of the environment and the genetic information of the individual].
    Roser M; Rüdiger HW
    Internist (Berl); 1989 Sep; 30(9):587-95. PubMed ID: 2681042
    [No Abstract]   [Full Text] [Related]  

  • 22. The chemical dynamics of mutagenesis and carcinogenesis. I. A chemical-kinetic model of dose-response relationships.
    Chandler JL
    Mutat Res; 1974 Nov; 25(2):169-78. PubMed ID: 4431421
    [No Abstract]   [Full Text] [Related]  

  • 23. ICPEMC to help protect against genetic diseases and cancer.
    WHO Chron; 1978 Oct; 32(10):400-1. PubMed ID: 716383
    [No Abstract]   [Full Text] [Related]  

  • 24. DNA repair in relation to biological monitoring of exposure to mutagens and carcinogens.
    Laval F; Huet J
    IARC Sci Publ; 1984; (59):371-85. PubMed ID: 6545289
    [No Abstract]   [Full Text] [Related]  

  • 25. Risk and reason. Risk assessment in relation to environmental mutagens and carcinogens. Proceedings of a satellite symposium to the Fourth International Conference on Environmental Mutagens. Oslo, Norway, June 21-22, 1985.
    Prog Clin Biol Res; 1986; 208():1-189. PubMed ID: 3960880
    [No Abstract]   [Full Text] [Related]  

  • 26. Analysis of in vivo mutation data can inform cancer risk assessment.
    Moore MM; Heflich RH; Haber LT; Allen BC; Shipp AM; Kodell RL
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):151-61. PubMed ID: 18321622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From fluorescence spectra to mutational spectra, a historical overview of DNA-reactive compounds.
    Lawley PD
    IARC Sci Publ; 1994; (125):3-22. PubMed ID: 7806320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability.
    Dosch J; Kaina B
    Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of genetic versus epigenetic mechanisms of toxicity and its application to risk assessment.
    Stott WT; Watanabe PG
    Drug Metab Rev; 1982; 13(5):853-73. PubMed ID: 6754312
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chemical mutagenesis at the molecular level].
    Otsuji N
    Tanpakushitsu Kakusan Koso; 1972 Jun; 17(6):414-22. PubMed ID: 4561589
    [No Abstract]   [Full Text] [Related]  

  • 31. Mutation and mutagenesis in inherited and acquired human disease. The first EEMS Frits Sobels Prize Lecture, Noordwijkerhout, The Netherlands, June 1995.
    Evans HJ
    Mutat Res; 1996 Apr; 351(2):89-103. PubMed ID: 8622717
    [No Abstract]   [Full Text] [Related]  

  • 32. Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours.
    Bignold LP
    Carcinogenesis; 2004 Mar; 25(3):299-307. PubMed ID: 14604890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What is the role of environmental mutagens for human cancer development?
    Sugimura T
    Prog Clin Biol Res; 1986; 209A():105-28. PubMed ID: 3529103
    [No Abstract]   [Full Text] [Related]  

  • 34. [Relaxation of natural selection: an academic controversy or a future medical problem?].
    Olarte G; Rothhammer F
    Rev Med Chil; 1974 Feb; 102(2):140-3. PubMed ID: 4157420
    [No Abstract]   [Full Text] [Related]  

  • 35. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 5/1: Perspectives in mutation epidemiology. 1. Incidence and prevalence of genetic disease (excluding chromosomal aberrations) in human populations.
    Matsunaga E
    Mutat Res; 1982 Jul; 99(1):95-128. PubMed ID: 6289095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation epidemiology: review and recommendations. A report to the International Commission for Protection against Environmental Mutagens and Carcinogens by Committee 5 (Epidemiology).
    Mutat Res; 1983 Sep; 123(1):1-11. PubMed ID: 6888411
    [No Abstract]   [Full Text] [Related]  

  • 37. Nickel (II) enhances benzo[a]pyrene diol epoxide-induced mutagenesis through inhibition of nucleotide excision repair in human cells: a possible mechanism for nickel (II)-induced carcinogenesis.
    Hu W; Feng Z; Tang MS
    Carcinogenesis; 2004 Mar; 25(3):455-62. PubMed ID: 14604891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic toxicology of environmental chemicals. Part B: Genetic effects and applied mutagenesis. Proceedings of the Fourth International Conference on Environmental Mutagens. Stockholm, Sweden, June 24-28, 1985.
    Prog Clin Biol Res; 1986; 209B():1-569. PubMed ID: 3749070
    [No Abstract]   [Full Text] [Related]  

  • 39. Two forms of repair in the DNA of human cells damaged by chemical carcinogens and mutagens.
    Regan JD; Setlow RB
    Cancer Res; 1974 Dec; 34(12):3318-25. PubMed ID: 4371955
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypothetical dose-response curves for chronic exposures to mutagens or carcinogens subject to simple enzymatic detoxification in the mammalian body.
    Bridges BA; Stamper JG
    Mutat Res; 1975 Nov; 33(1 Spec No):87-91. PubMed ID: 1202343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.